Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
Meta-analysis published in Medicine (2021)
Abstract
INTRODUCTION: Proliferative vitreous retinopathy (PVR) is characterized by proliferation of cells and contraction of membranes on either the retinal surface or in the vitreous cavity, which leads to retinal detachment and visual impairment. PVR is commonly seen in patients with rhegmatogenous retinal detachment and diabetic retinopathy, which seriously affects the patient's work and life. Previous studies indicated that Hirudo (Leech) or compound prescription containing Hirudo (Leech) for treatment of PVR would be effective. However, due to the lack of evidence, there are no specific methods or suggestions, so it is necessary to carry out systematic evaluations on Hirudo (Leech) for PVR and provide effective evidence for further research. METHODS AND ANALYSIS: The following 8 databases will be searched: Cochrane Central Register of Controlled Trials, PubMed, MEDLINE, EMBASE, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database, and Wanfang Database. All randomized controlled trials in English or Chinese related to Hirudo (Leech) for PVR will be included. Outcomes will include change in Vitreous opacity, Vision changes, production of the anterior macular membrane, and retinal detachment again. The incidence of adverse events will be assessed for safety evaluation. Study inclusion, data extraction and quality assessment will be performed independently by 2 reviewers. Assessment of risk of bias and data synthesis will be performed using Review Manager V.5.3. RESULTS: In this systematic review and meta-analysis, we will synthesize the studies to assess the safety and efficacy of Hirudo (Leech) for PVR. CONCLUSION: The summary of our study will clarify whether Hirudo (Leech) therapy could be an efficient and safe method for PVR, which can further guide the promotion and application of it. OPEN SCIENCE FRAMEWORK OSF REGISTRATION NUMBER: 10.17605/OSF.IO/FP7VG (https://osf.io/fp7vg).
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Proliferative vitreous retinopathy (PVR) is characterized by proliferation of cells and contraction of membranes on either the retinal surface or in the vitreous cavity, which leads to retinal detachment and visual impairment.
Por qué esto importa para la hirudoterapia
Este artículo presenta un protocolo registrado para una revisión sistemática y un metaanálisis que evalúa la seguridad y la eficacia de Hirudo (sanguijuela) o de prescripciones compuestas que contienen Hirudo para la retinopatía vitreoproliferativa (PVR), una afección caracterizada por proliferación celular y contracción de membranas que puede causar desprendimiento de retina. Los autores esbozan planes para buscar en ocho bases de datos ensayos controlados aleatorizados en inglés o chino, evaluando desenlaces como opacidad vítrea, cambios visuales, desprendimiento de retina recidivante y eventos adversos. Este trabajo es directamente relevante para la hirudoterapia, ya que pretende evaluar críticamente y sintetizar la evidencia de ensayos clínicos sobre intervenciones basadas en sanguijuelas en una patología oftalmológica donde estudios previos han sugerido beneficio terapéutico. No obstante, se trata únicamente de un protocolo: no se han realizado búsquedas, no se han extraído datos y no se han sintetizado resultados, por lo que aún no pueden extraerse evidencias, estimaciones de efecto ni conclusiones de seguridad; el valor último dependerá de la finalización de la revisión planificada y de la calidad y cantidad de ensayos identificados.
Citación
Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis.
Huang H et al. · Medicine, 2021
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: June 18, 2026